RecruitingNot ApplicableNCT06909500

A Digital Intervention (ACT on Vaping App) for Vaping Cessation in Young Adult E-Cigarette Users

ACT on Vaping: Digital Therapeutic for Young Adult Vaping Cessation


Sponsor

Fred Hutchinson Cancer Center

Enrollment

1,178 participants

Start Date

May 20, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This clinical trial evaluates a smartphone application (app) called Acceptance and Commitment Therapy (ACT) on Vaping for helping young adults quit using electronic cigarettes (e-cigarettes). E-cigarettes pose numerous risks, particularly to youth and young adults. Addressing the high prevalence of e-cigarette use by young adults requires effective and accessible treatments to support current users to quit. Research shows this group prefers and benefits from newer methods of treatment delivery such as digital interventions. ACT on Vaping is a digital therapeutic intended to deliver behavioral therapy to young adults who vape to motivate and support abstinence from all nicotine and tobacco products. The app contains sessions that promote awareness of cues that trigger tobacco use and teach skills for responding to these triggers in a way that is tailored for the participant's readiness to quit. Receiving access to the ACT on Vaping app may be effective in helping young adults quit vaping.


Eligibility

Min Age: 18 YearsMax Age: 30 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called Smartphone app, a behavioral approach called Smartphone app, and others for people with nicotine dependence and tobacco-related carcinoma. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 30 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALSmartphone app

Receive access to the ACT on Vaping app

BEHAVIORALSmartphone app

Receive access to the ACT on Vaping app

OTHERText Message

Receive incentivized text messages to access vaping status

OTHERText Message

Receive intervention text messages

OTHERSurvey Administration

Ancillary studies


Locations(1)

Fred Hutch/University of Washington Cancer Consortium

Seattle, Washington, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06909500


Related Trials